This paper was written in November 2024 prior to the inauguration of President Trump, and as such does not reflect or account for the changes that have occurred in the development space since then due ...

Despite advancements in melanoma therapy, the prognosis remains unfavorable for many patients. The proteasome inhibitor MG132 has shown therapeutic potential through pathway regulation, yet its ...

School of Materials Science and Chemical Engineering, Harbin University of Science and Technology, 150080 Harbin, China ...